ImmuCell Corporation Prepaid Expense and Other Assets, Current
ImmuCell Corporation (ICCC) had Prepaid Expense and Other Assets, Current of $244.08 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › and Other Assets
us-gaap:PrepaidExpenseAndOtherAssetsCurrent · last filed 2026-08-13
- 2026-06-30: Prepaid Expense and Other Assets, Current $244.08K.
- 2026-03-31: Prepaid Expense and Other Assets, Current $681.22K.
- 2025-12-31: Prepaid Expense and Other Assets, Current $451.67K.
- 2025-09-30: Prepaid Expense and Other Assets, Current $582.21K.
| Period end | Prepaid Expense and Other Assets, Current | Prepaid Expense and Other Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $244.08K 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $681.22K 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $451.67K 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $582.21K 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $464.57K 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $616.48K 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $400.76K 10-K · filed 2026-03-30 | |
| 2024-09-30 | $310.49K 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $219.57K 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $615.20K 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $493.88K 10-K · filed 2025-03-28 | |
| 2023-09-30 | $722.39K 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $456.38K 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $733.62K 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $406.06K 10-K · filed 2024-04-01 | |
| 2022-09-30 | $585.72K 10-Q · filed 2022-11-21 | |
| 2022-06-30 | $268.35K 10-Q/A · filed 2022-11-21 | |
| 2022-03-31 | $393.54K 10-Q/A · filed 2022-11-21 | |
| 2021-12-31 | $295.20K 10-K · filed 2023-03-29 | |
| 2021-09-30 | $490.50K 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $360.77K 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $490.53K 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $321.26K 10-K · filed 2022-03-30 | |
| 2020-09-30 | $393.16K 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $251.84K 10-Q · filed 2020-08-12 | |
| 2020-03-31 | $475.08K 10-Q · filed 2020-05-13 | |
| 2019-12-31 | $259.57K 10-K · filed 2021-03-30 | |
| 2019-09-30 | $502.27K 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $657.59K 10-Q · filed 2019-08-12 | |
| 2019-03-31 | $755.24K 10-Q · filed 2019-05-13 | |
| 2018-12-31 | $635.82K 10-K · filed 2020-03-27 | |
| 2018-09-30 | $720.85K 10-Q · filed 2018-11-13 | |
| 2018-06-30 | $487.38K 10-Q · filed 2018-08-13 | |
| 2018-03-31 | $401.74K 10-Q · filed 2018-05-14 | |
| 2017-12-31 | $314.67K 10-K · filed 2019-03-22 | |
| 2017-09-30 | $361.80K 10-Q · filed 2017-11-13 | |
| 2017-06-30 | $378.95K 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $570.90K 10-Q · filed 2017-05-11 | |
| 2016-12-31 | $604.48K 10-K · filed 2018-03-29 | |
| 2016-09-30 | $693.46K 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $503.09K 10-Q · filed 2016-08-11 | |
| 2016-03-31 | $297.90K 10-Q · filed 2016-05-11 | |
| 2015-12-31 | $247.48K 10-K · filed 2017-03-30 | $211.78K 10-K · filed 2016-03-25 |
| 2015-09-30 | $275.56K 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $290.14K 10-Q · filed 2015-08-13 | |
| 2015-03-31 | $178.62K 10-Q · filed 2015-05-12 | |
| 2014-12-31 | $148.40K 10-K · filed 2016-03-25 | |
| 2014-09-30 | $336.62K 10-Q · filed 2014-11-12 | |
| 2013-12-31 | $159.12K 10-K · filed 2015-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |